Received Mar 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
wondering if this patient can receive a shot of the SHINGRIX Prefilled Syringe, do they have to restart the series; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose with two vial two years ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, the patient had incomplete course of vaccination (Verbatim: wondering if this patient can receive a shot of the SHINGRIX Prefilled Syringe, do they have to restart the series). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date:09-MAR-2026 The pharmacist reported that the patient received two vial Shingrix vaccine two years ago and they are wondering if this patient could receive a shot of the Shingrix prefilled syringe, did they have to restart the series, what could they (no adverse event was generated from the general response center´s end).